With technology reaching into nearly every aspect of human life, at a faster rate than ever, it’s inevitable that tech firms would turn their attention to health care. In an interview with CNBC, Yitzhak Peterburg, the president and CEO of Israel-based Teva Pharmaceuticals said that pharmaceutical firms should prepare for disruption, and potential competition, from tech firms.
According to Peterburg, who runs what is said to be the world’s largest producer of generic drugs, is not only looking at other pharmaceutical firms. He now sees tech companies like Amazon and Google as potential competitors. It’s well-known that tech companies are researching on how to enter the multi-billion dollar health care industry.
More venture capitalists are pouring money into health technology startups. These startups, in turn, are hiring more biomedical experts as advisors. Some of the more obvious health care areas that tech firms can enter involve the storage and distribution of patients’ medical history and related information. Reportedly, Apple is working to have patients’ medical information made available on iPhones.
Tech firms can go beyond medical data. Amazon, for example, might end up competing with pharmacies if it implements a plan to sell medications online. It would be no surprise if a tech firm offers, one day, a diagnostic test, or even a treatment that would be touted as better than what pharmaceutical and healthcare firms are selling.
In fact, one tech company has done exactly that, but with disastrous, cautionary results. Elizabeth Holmes, the founder of health technology start-up Theranos, was once ranked by Forbes as one of the richest self-made women, with a net worth of $4.1 billion. When the Theranos scandal unfolded, Forbes revised its ranking of Holmes, putting her net worth at zero.
Holmes had apparently modeled herself after Steve Jobs and promised to change health care with technology. She promised investors and the public that her device, called the Edison, was able to conduct a wide range of tests using only a pinprick of blood from a finger. Some experts doubted this, but Holmes pushed on.
Some criticized her for running Theranos like a tech firm instead of a medical or healthcare company. Like Steve Jobs, she demanded secrecy from employees and managers, and refused to listen to advisers who were actual scientists and medical experts. She refused to publish papers in peer reviewed medical journals and allow experts to assess if her diagnostic test really worked.
Later on, after investigations by the media, government regulators, and the FBI, there was a general consensus that the Edison did not work. It was also revealed that blood tests done at Theranos clinics were wildly inaccurate. This put patients’ health and lives in danger. Vanity Fair’s special report on the Theranos debacle is particularly interesting.
Theranos remains a cautionary tale with one glaring lesson: tech firms, if they get into health care and medicine, should concern themselves with more than just technology. They should make sure they get the medical science right, and be transparent about it.
The surprising ways small businesses can be more efficient using live chats
Understanding customers has always been the key to improving conversion rates. Live chat is one more tool available to make...
How permanent is your cannabis stock?
Cannabis is still illegal in some places yet its industry is booming. What does this mean for cannabis investments?
How environmental investment makes businesses competitive
As the world needs to address climate change, it is possible to be environment friendly while being profitable?
4 conditions you need for a world-changing idea
Breakthrough ideas don't just magically appear. There are conditions that precede world-changing concepts.
3 red flags to watch out for in a would-be retail space
Before you decide on signing a lease for that new retail space you found, you should also consider the possible...
- Featured4 days ago
Soybean market down as US-China trade deal remains unresolved
- Crypto5 days ago
Bitcoin’s bounce back highlights the need for a better cryptocurrency portfolio tracker
- Featured3 days ago
How fintech is positively impacting the energy sector
- Business3 days ago
The process of rebranding your business website this 2019